Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1323099 (sympathomimetic)
 2,957 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The vascular effects of serotonin and the selective 5-HT2 antagonist ketanserin were investigated in the forearm of healthy subjects. The drugs were infused into the brachial artery in doses that did not elicit systemic hemodynamic effects (0.1-80 ng/kg/min for serotonin and 5-125 ng/kg/min for ketanserin). The interaction between serotonin and ketanserin was studied by combined infusions of serotonin with ketanserin, and the relative 5-HT2 and alpha 1-adrenoceptor blocking potencies of ketanserin were studied by simultaneous infusions of the selective alpha 1-agonist methoxamine, the indirect sympathomimetic drug tyramine, and serotonin with two doses of ketanserin. Forearm blood flow (FBF) was measured by venous occlusion plethysmography. Heart rate and intra-arterial blood pressure were recorded continuously. All doses of serotonin induced an initial transient vasodilation that was followed by a steady vasodilation for the lower doses (0.1-10 ng/kg/min) and a steady vasoconstriction for the highest dose of serotonin (p less than 0.05). Ketanserin induced a dose-dependent vasodilation, which was significant from the dose of 15 ng/kg/min (p less than 0.05). The vasodilation induced by serotonin (1 ng/kg/min) was significantly enhanced by ketanserin, whereas the vasoconstriction elicited by serotonin of 80 ng/kg/min was reversed by ketanserin (p less than 0.05). The vasoconstriction induced by methoxamine and tyramine was attenuated at a lower dose of ketanserin than the vascular response induced by serotonin. It is concluded that serotonin acts mainly as a vasodilatator in healthy subjects, whereas only at very high doses is vasoconstriction mediated by 5-HT2 receptors observed. The vasodilation induced by ketanserin is most likely due to its alpha 1-adrenoceptor blocking potencies.
 ...
PMID:Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm. 245 13

Isolated hand arteries and veins from healthy human subjects were tested in vitro for their contractile response to adrenergic agonists and 5-hydroxytryptamine (5-HT) under standardized conditions. This allowed for quantitative estimation of various receptor characteristics. The relative sympathomimetic potency suggested alpha-adrenergic receptors, which was confirmed in Schild plots following phentolamine antagonism of the response (pA2 for artery 7.57, for vein 7.75). 5-HT contracted with a relative potency approximately equal to noradrenaline and adrenaline in arteries, but only one fifth to one tenth of the catecholamine activity in veins. Ketanserin inhibited the 5-HT response in a competitive, probably also irreversible, manner in arteries (pA2 9.50, KA 8.90 X 10(-7) M). In the veins, ketanserin counteracted the 5-HT-induced contraction in a noncompetitive way.
 ...
PMID:Adrenergic and serotoninergic mechanisms in human hand arteries and veins studied by fluorescence histochemistry and in vitro pharmacology. 315 33